More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not ...
The ability of different genetic variants—changes to one or more building blocks of DNA—to cause disease, and to what extent, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results